Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Non-small-cell lung carcinoma | D002289 | — | — | 5 | 5 | 4 | — | — | 12 |
Breast neoplasms | D001943 | EFO_0003869 | C50 | 2 | 2 | 3 | — | — | 6 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Triple negative breast neoplasms | D064726 | — | — | 3 | 3 | — | — | — | 4 |
Colorectal neoplasms | D015179 | — | — | 1 | 2 | — | — | — | 2 |
Ovarian neoplasms | D010051 | EFO_0003893 | C56 | 1 | 2 | — | — | — | 2 |
Endometrial neoplasms | D016889 | EFO_0004230 | — | 1 | 2 | — | — | — | 2 |
Stomach neoplasms | D013274 | EFO_0003897 | C16 | 1 | 2 | — | — | — | 2 |
Hemangiosarcoma | D006394 | — | — | — | 1 | — | — | — | 1 |
Prostatic neoplasms | D011471 | — | C61 | 1 | 1 | — | — | — | 1 |
Pancreatic neoplasms | D010190 | EFO_0003860 | C25 | 1 | 1 | — | — | — | 1 |
Urinary bladder neoplasms | D001749 | — | C67 | 1 | 1 | — | — | — | 1 |
Uterine cervical neoplasms | D002583 | HP_0030159 | — | 1 | 1 | — | — | — | 1 |
Drug common name | Datopotamab deruxtecan |
INN | datopotamab deruxtecan |
Description | Ds-1062 is an unknown pharmaceutical. It is currently being investigated in clinical studies. |
Classification | Unknown |
Drug class | — |
Image (chem structure or protein) | |
Structure (InChI/SMILES or Protein Sequence) | — |
PDB | — |
CAS-ID | — |
RxCUI | — |
ChEMBL ID | CHEMBL4297939 |
ChEBI ID | — |
PubChem CID | — |
DrugBank | — |
UNII ID | GD2OWY1DTK (ChemIDplus, GSRS) |